Budesonide oral suspension for inducing and maintaining remission of eosinophilic oesophagitis in people 2 to 17 years [ID6761]

  • Awaiting development
  • GID-TA12464
  • Expected publication date: TBC

Documents

Documents created during the development process.

Notes